The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Amgen Inc

Nasdaq: AMGN
Last

(U.S.) $170.23

Today's change-0.61 -0.36%
Updated August 25 4:00 PM EDT. Delayed by at least 15 minutes.
 

Amgen Inc

Nasdaq: AMGN
Last

(U.S.) $170.23

Today's change-0.61 -0.36%
Updated August 25 4:00 PM EDT. Delayed by at least 15 minutes.

Amgen Inc down (U.S.)$0.61

Amgen Inc closed lower Thursday, dropping (U.S.)$0.61 or 0.36% to (U.S.)$170.23. Shares have lost 2.59% over the last five days, but sit 3.63% below their 52-week high. This security has performed in-line with the S&P 500 during the last year.

Key company metrics

  • Open(U.S.) $169.92
  • Previous close(U.S.) $170.84
  • High(U.S.) $171.46
  • Low(U.S.) $168.76
  • Bid / Ask(U.S.) $169.50 / (U.S.) $170.80
  • YTD % change+4.87%
  • Volume2,622,489
  • Average volume (10-day)2,614,829
  • Average volume (1-month)2,875,857
  • Average volume (3-month)2,856,432
  • 52-week range(U.S.) $130.09 to (U.S.) $176.64
  • Beta0.88
  • Trailing P/E17.42×
  • P/E 1 year forward15.03×
  • Forward PEG1.77×
  • Indicated annual dividend(U.S.) $4.00
  • Dividend yield2.35%
  • Trailing EPS(U.S.) $9.77
Updated August 25 4:00 PM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015
Revenue5,6885,5275,5365,723
Total other revenue--------
Total revenue5,6885,5275,5365,723
Gross profit4,6384,5094,4654,689
Total cost of revenue1,0501,0181,0711,034
Total operating expense3,3083,1253,5033,384
Selling / general / administrative1,2921,2031,4161,244
Research & development9008721,0931,119
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)7827-846
Other operating expenses, total-1257-19
Operating income2,3802,4022,0332,339
Interest income (expense), net non-operating-313-294-284-282
Gain (loss) on sale of assets--------
Other--------
Income before tax2,2042,2581,9132,192
Income after tax1,8701,9001,8001,863
Income tax, total334358113329
Net income1,8701,9001,8001,863
Total adjustments to net income--------
Net income before extra. items1,8701,9001,8001,863
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1,8701,9001,8001,863
Inc. avail. to common incl. extra. items1,8701,9001,8001,863
Diluted net income1,8701,9001,8001,863
Dilution adjustment--------
Diluted weighted average shares756760763764
Diluted EPS excluding extraordinary itemsvalue per share2.472.502.362.44
Dividends per sharevalue per share1.001.000.790.79
Diluted normalized EPSvalue per share2.562.532.262.45